Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombocytopenia Chemotherapy Induced”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06745219
What this trial is testing

Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer

Who this might be right for
ThrombopeniaCervical CancerRadiotherapy Side Effect+1 more
Peking University Cancer Hospital & Institute 30
Not applicableStudy completedNCT05688306
What this trial is testing

To Evaluate Thrombosis Risk in Chemotherapy Patients With Solid Tumors Who Receiving Thrombocytopenia Treatment

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Liaoning Cancer Hospital & Institute 3,494
Testing effectiveness (Phase 2)Ended earlyNCT02227576
What this trial is testing

Prevention of Thrombocytopenia in Glioblastoma Patients

Who this might be right for
ThrombocytopeniaGlioblastoma
University Hospital, Lille 20
Testing effectiveness (Phase 2)Looking for participantsNCT07063225
What this trial is testing

Romiplostim N01 for Chemotherapy-induced Thrombocytopenia

Who this might be right for
Chemotherapy-induced ThrombocytopeniaRomiplostim N01
Institute of Hematology & Blood Diseases Hospital, China 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243418
What this trial is testing

Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study

Who this might be right for
CTIT-Chemotherapy Induced ThrombocytopeniaBreast Cancer
Fujian Cancer Hospital 72
Testing effectiveness (Phase 2)Study completedNCT00413283
What this trial is testing

Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerChemotherapy-Induced ThrombocytopeniaNon-Small Cell Lung Cancer+5 more
Amgen 63
Large-scale testing (Phase 3)Study completedNCT05554913
What this trial is testing

Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Qilu Pharmaceutical Co., Ltd. 63
Testing effectiveness (Phase 2)Looking for participantsNCT07043894
What this trial is testing

Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients

Who this might be right for
Solid TumorsHematological TumorChildren+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Large-scale testing (Phase 3)Study completedNCT02578901
What this trial is testing

American Trial Using Tranexamic Acid in Thrombocytopenia

Who this might be right for
Thrombocytopenia
University of Washington 330
Early research (Phase 1)Study completedNCT00359463
What this trial is testing

Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 33
Early research (Phase 1)Ended earlyNCT01491594
What this trial is testing

Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia

Who this might be right for
Sarcoma, Soft TissueOsteosarcomaNeoplasms, Connective and Soft Tissue
Duke University 1
Testing effectiveness (Phase 2)Ended earlyNCT03622931
What this trial is testing

Patients With Relapsed Ovarian Cancer (2nd and 3rd Line) Treated With Chemotherapy According to AGO Guidelines

Who this might be right for
Ovarian Cancer
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 21
Testing effectiveness (Phase 2)Looking for participantsNCT07492693
What this trial is testing

Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors

Who this might be right for
Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors
Changhai Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT05236582
What this trial is testing

Herombopag for Chemotherapy-induced Thrombocytopenia

Who this might be right for
Chemotherapy-induced ThrombocytopeniaHerombopag
Institute of Hematology & Blood Diseases Hospital, China 50
Large-scale testing (Phase 3)UnknownNCT06440824
What this trial is testing

Randomized Controlled Study on the Treatment of Refractory CTIT With Romiplostim N01 Compared to Recombinant Human Thrombopoietin

Who this might be right for
CTIT-Chemotherapy Induced Thrombocytopenia
Shandong University 60
Post-approval studies (Phase 4)UnknownNCT03633019
What this trial is testing

High-dose Use of rhTPO in CIT Patients

Who this might be right for
Thrombocytopenia
First Affiliated Hospital Xi'an Jiaotong University 50
Testing effectiveness (Phase 2)Ended earlyNCT01676961
What this trial is testing

Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+2 more
NYU Langone Health 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07252375
What this trial is testing

A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)CTIT-Chemotherapy Induced Thrombocytopenia
Fujian Cancer Hospital 35
Testing effectiveness (Phase 2)Study completedNCT01890746
What this trial is testing

A Safety and Efficacy Study of Eltrombopag in Subjects With AML

Who this might be right for
Acute Leukaemia
Novartis Pharmaceuticals 148
Very early researchLooking for participantsNCT07048249
What this trial is testing

Single Arm Romiplostim to Prevent CIT

Who this might be right for
Ewings SarcomaChemotherapy Induced Thrombocytopenia
Children's Hospital Medical Center, Cincinnati 26
Next Page